Results 61 to 70 of about 176,716 (160)

Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer. [PDF]

Angiogenesis
Gomez-Escudero J, Maniati E, Holdsworth J, Beattie G, Hijazi M, Guelbert M, Elorbany S, Cutillas P, Wang J, Hodivala-Dilke K, D'Amico G.   +10 more
europepmc   +1 more source

Post-marketing safety evaluation of anthracycline for acute myeloid leukemia treatment: a real-world pharmacovigilance analysis. [PDF]

Front Pharmacol
Wang Y, Liu Q, Xu J, Yang F, Wang M, Lu H, Wu J, Zhang A, Zhang X, Wu D, Qiu H.   +10 more
europepmc   +1 more source

RETRACTION: Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice. [PDF]

Dis Markers
Markers D.
europepmc   +1 more source

Clinical Outcome in Elderly Patients (Aged ≥ 65 Years) Treated with Chemotherapy for Advanced Soft Tissue Sarcomas: A Tokai Musculoskeletal Oncology Consortium Study. [PDF]

Cancers (Basel)
Nakamura T, Tsukushi S, Nagano A, Sakai T, Aiba H, Wasa J, Hosono K, Shido Y, Izubuchi Y, Shimoyama T, Kawanami K, Kozawa E, Hasegawa M, Nishida Y.   +13 more
europepmc   +1 more source

Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models. [PDF]

Cells
Bensa V, Lopes-Cardoso H, Ardito M, Ciampi E, Voronovska A, Soares-Gonçalves J, Ponzoni M, Brignole C, Moreira JN, Pastorino F.   +9 more
europepmc   +1 more source

Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity. [PDF]

Cancer Res Commun
Wang Q, Zhang W, Chen J, Stenson KT, Parsai S, Parthasarathy PB, Liu CF, Garrett T, Lin J, Hou A, Shimpi RA, Gu E, Yin M, Shannon L, Johnson S, Willard BB, Rodriguez ER, Androjna C, Moudgil R, Sun Y, Yu JS, Nguyen C, Alban TJ, Chan TA, Prasad SVN, Tang WHW, Lin J, Zhao J.   +27 more
europepmc   +1 more source

Characteristics and Outcomes of Patients With Dedifferentiated Liposarcoma in a US Community Setting. [PDF]

Cancer Med
Butrynski JE, Nepal B, Hu C, Guo J, Han J, Herms L, Klein AB, Stanhope S, Stanley EL, Todoroff K, Conkling P.   +10 more
europepmc   +1 more source

Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers. [PDF]

Transl Oncol
Cogoluegnes S, Kovachka S, Dubois T, Würth R, Donato E, Trumpp A, Franco M, Luton F, Azoulay S, Mus-Veteau I.   +9 more
europepmc   +1 more source

Structural and morphological modulation of the myocardium by <i>Dioscorea bulbifera</i> saponins in experimentally induced cardiotoxicity. [PDF]

Biochem Biophys Rep
Saka OS, Komolafe OA, Ogunlade O, Enye LA, Saka AA, Oladimeji MO, Arayombo BE, Ayegbusi OS.   +7 more
europepmc   +1 more source

Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice. [PDF]

Support Care Cancer
Ditta SA, Jongbloed F, Manintveld OC, Brugma JD, Wlazlo N, Bos MEMM, van der Kuy HM, Mathijssen RHJ.   +7 more
europepmc   +1 more source